Strong dollar eats into J&J quarterly sales

October 13, 2015 11:33 AM

33 0

Strong dollar eats into J&J quarterly sales

Johnson & Johnson (JNJ.N) reported a 7.4 percent fall in quarterly sales as the impact of a strong dollar more than offset higher sales of its older drugs such as Invega line of products for schizophrenia and ADHD treatment Concerta.

Revenue fell to $17.10 billion in the third quarter from $18.47 billion a year earlier.

Also read: KKR buys smart meter financing firm Calvin Capital

Read more

To category page

Loading...